New therapies for people with CF in the CFTR modulator world

被引:1
作者
Wainwright, Claire E. [1 ]
机构
[1] Univ Queensland, Child Hlth Res Ctr, 62 Graham St, South Brisbane, Qld 4101, Australia
关键词
CYSTIC-FIBROSIS; TEZACAFTOR-IVACAFTOR; EFFICACY;
D O I
10.1016/j.jcf.2020.07.019
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:669 / 670
页数:2
相关论文
共 9 条
[1]   Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation [J].
Davies, Jane C. ;
Wainwright, Claire E. ;
Canny, Gerard J. ;
Chilvers, Mark A. ;
Howenstine, Michelle S. ;
Munck, Anne ;
Mainz, Jochen G. ;
Rodriguez, Sally ;
Li, Haihong ;
Yen, Karl ;
Ordonez, Claudia L. ;
Ahrens, Richard .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187 (11) :1219-1225
[2]   Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view [J].
De Boeck, K. ;
Lee, T. ;
Amaral, M. ;
Drevinek, P. ;
Elborn, J. S. ;
Fajac, I ;
Kerem, E. ;
Davies, J. C. .
JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (05) :688-695
[3]   The US Food and Drug Administration's Experience with Ivacaftor in Cystic Fibrosis Establishing Efficacy Using In Vitro Data in Lieu of a Clinical Trial [J].
Durmowicz, Anthony G. ;
Lim, Robert ;
Rogers, Hobart ;
Rosebraugh, Curtis J. ;
Chowdhury, Badrul A. .
ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (01) :1-2
[4]   Acronyms Confuse Everyone: Combating the use of acronyms to describe paediatric research studies [J].
Isles, Alan F. ;
Pearn, John H. .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2014, 50 (10) :756-758
[5]   Building global development strategies for cf therapeutics during a transitional cftr modulator era [J].
Mayer-Hamblett, N. ;
Van Koningsbruggen-Rietschel, S. ;
Nichols, D. P. ;
VanDevanter, D. R. ;
Davies, J. C. ;
Lee, T. ;
Durmowicz, A. G. ;
Ratjen, F. ;
Konstan, M. W. ;
Pearson, K. ;
Bell, S. C. ;
Clancy, J. P. ;
Taylor-Cousar, J. L. ;
De Boeck, K. ;
Donaldson, S. H. ;
Downey, D. G. ;
Flume, P. A. ;
Drevinek, P. ;
Goss, C. H. ;
Fajac, I ;
Magaret, A. S. ;
Quon, B. S. ;
Singleton, S. M. ;
VanDalfsen, J. M. ;
Retsch-Bogart, G. Z. .
JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (05) :677-687
[6]   Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele [J].
Middleton, P. G. ;
Mall, M. A. ;
Drevinek, P. ;
Lands, L. C. ;
McKone, E. F. ;
Polineni, D. ;
Ramsey, B. W. ;
Taylor-Cousar, J. L. ;
Tullis, E. ;
Vermeulen, F. ;
Marigowda, G. ;
Mckee, C. M. ;
Moskowitz, S. M. ;
Nair, N. ;
Savage, J. ;
Simard, C. ;
Tian, S. ;
Waltz, D. ;
Xuan, F. ;
Rowe, S. M. ;
Jain, R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (19) :1809-1819
[7]   A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation [J].
Ramsey, Bonnie W. ;
Davies, Jane ;
McElvaney, N. Gerard ;
Tullis, Elizabeth ;
Bell, Scott C. ;
Drevinek, Pavel ;
Griese, Matthias ;
McKone, Edward F. ;
Wainwright, Claire E. ;
Konstan, Michael W. ;
Moss, Richard ;
Ratjen, Felix ;
Sermet-Gaudelus, Isabelle ;
Rowe, Steven M. ;
Dong, Qunming ;
Rodriguez, Sally ;
Yen, Karl ;
Ordonez, Claudia ;
Elborn, J. Stuart .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (18) :1663-1672
[8]   Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del [J].
Taylor-Cousar, Jennifer L. ;
Munck, Anne ;
McKone, Edward F. ;
van der Ent, Cornelis K. ;
Moeller, Alexander ;
Simard, Christopher ;
Wang, Linda T. ;
Ingenito, Edward P. ;
Mckee, Charlotte ;
Lu, Yimeng ;
Lekstrom-Himes, Julie ;
Elborn, J. Stuart .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21) :2013-2023
[9]   Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR [J].
Wainwright, C. E. ;
Elborn, J. S. ;
Ramsey, B. W. ;
Marigowda, G. ;
Huang, X. ;
Cipolli, M. ;
Colombo, C. ;
Davies, J. C. ;
De Boeck, K. ;
Flume, P. A. ;
Konstan, M. W. ;
McColley, S. A. ;
Mccoy, K. ;
McKone, E. F. ;
Munck, A. ;
Ratjen, F. ;
Rowe, S. M. ;
Waltz, D. ;
Boyle, M. P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (03) :220-231